TNFRSF4 and acute myeloid leukemia: In addition, based on our clinical center data, we validated TNFRSF4 expression level of non-M3 AML patients was significantly higher than that of HDs and Myelodysplastic syndrome (MDS) Excess blasts (EB)-1,2 patients.